CIK 0001590750
- Large accelerated filer
Viridian Therapeutics, Inc.\DE
Sign in to watch- Ticker
- VRDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471187261
- Phone
- +1 617-272-4600
- Business address
- 221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
- Former names
- MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $348,194
- in 1 filing
Net −$348,194. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 15 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-11 | Fairmount Funds Management LLC Director | Purchase | +1,176,470 | $17.00 | $20.0M | 5,090,928 |
| 2025-10-23 | Fairmount Funds Management LLC Director | Purchase | +454,545 | $22.00 | $10.0M | 3,914,458 |
| 2025-06-10 | Fairmount Funds Management LLC Director | Option exercise | +12,500 | $12.31 | $154K | 3,459,913 |
| 2025-06-10 | Fairmount Funds Management LLC Director | Option exercise · Stock Option (Right to Buy) | −12,500 | 0 | ||
| 2025-06-09 | Fairmount Funds Management LLC Director | Option exercise | +1,600 | $7.80 | $12K | 3,447,413 |
| 2025-06-09 | Fairmount Funds Management LLC Director | Option exercise · Stock Option (Right to Buy) | −1,600 | 0 | ||
| 2024-09-13 | Fairmount Funds Management LLC Director | Purchase | +1,600,000 | $18.75 | $30.0M | 3,445,813 |
| 2024-03-28 | Fairmount Funds Management LLC Director | Other disposition | −5,859 | 0 | ||
| 2024-03-28 | Fairmount Funds Management LLC Director | Other acquisition | +5,859 | 1,845,813 | ||
| 2024-03-28 | Fairmount Funds Management LLC Director | Other disposition · Series A Non-Voting Convertible Preferred Stock | −21,999 | 0 | ||
| 2024-03-28 | Fairmount Funds Management LLC Director | Other acquisition · Series A Non-Voting Convertible Preferred Stock | +21,999 | 133,191 | ||
| 2024-01-22 | Fairmount Funds Management LLC Director | Purchase | +476,190 | $21.00 | $10.0M | 1,839,954 |
| 2023-10-30 | Fairmount Funds Management LLC Director | Grant or award · Series B Non-Voting Convertible Preferred Stock | +48,463 | $825.37 | $40.0M | 48,463 |
| 2022-08-17 | Fairmount Funds Management LLC Director | Purchase | +425,531 | $23.50 | $10.0M | 1,363,764 |
| 2021-09-21 | Fairmount Funds Management LLC Director | Purchase | +909,000 | $11.00 | $10.0M | 938,233 |
| 2020-10-30 | Fairmount Funds Management LLC Director | Purchase · Series A Non-Voting Convertible Preferred Stock | +5,494 | $465.96 | $2.6M | 21,999 |
| 2020-10-30 | Fairmount Funds Management LLC Director | Purchase · Series A Non-Voting Convertible Preferred Stock | +28,843 | $465.96 | $13.4M | 111,192 |
| 2020-10-27 | Fairmount Funds Management LLC Director | Other acquisition | +87,891 | 87,891 | ||
| 2020-10-27 | Fairmount Funds Management LLC Director | Other acquisition | +438,502 | 438,502 | ||
| 2020-10-27 | Fairmount Funds Management LLC Director | Other acquisition · Series A Non-Voting Convertible Preferred Stock | +16,505 | 16,505 |
Page 1 of 2 · 21 trades